Bio-Rad Laboratories, Inc. beat EPS estimates 50% of the time across 2 reported quarters (1 beats, 1 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $2.34 | $2.62 | +12.0% | Beat |
| Q12026 FY2026 | $2.77 | $1.89 | -31.8% | Miss |
| Q42025 FY2025 | $2.57 | — | — | Miss |
Back to BIO overview · BIO holders · BIO KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.